Cargando…
Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options
BRAF mutations occur in up to 50% of melanomas. Mutations in the BRAF gene directly influence the patient's treatment because several inhibitors are available that only target BRAF(V600) mutations. Herein, we describe two cases of patients with metastatic melanomas, each carrying a ‘nonstandard...
Autores principales: | Richtig, Georg, Aigelsreiter, Ariane, Kashofer, Karl, Talakic, Emina, Kupsa, Romana, Schaider, Helmut, Richtig, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075727/ https://www.ncbi.nlm.nih.gov/pubmed/27790118 http://dx.doi.org/10.1159/000449125 |
Ejemplares similares
-
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study
por: Berger, Marina, et al.
Publicado: (2021) -
Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017) -
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy
por: Schrom, Silke, et al.
Publicado: (2021) -
Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib
por: Deinlein, Teresa, et al.
Publicado: (2017) -
Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma
por: Richtig, Georg, et al.
Publicado: (2019)